Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation

被引：12
|
作者：
Ali, Saad Ahmad [1 ]
Arman, Huseyin Emre [1 ]
Patel, Anuj Amrut [2 ]
Birhiray, Ruemu Ejedafeta [3 ]
机构：
[1] Marian Univ, Coll Osteopath Med, Indianapolis, IN USA
[2] Northwest Radiol, Indianapolis, IN USA
[3] Hematol Oncol Indiana, 8550 Naab Rd,Suite 205, Indianapolis, IN 46260 USA
来源：
JCO ONCOLOGY PRACTICE | 2020年 / 16卷 / 03期
关键词：
SKIN-CANCER; RECIPIENTS;
D O I：
10.1200/JOP.19.00567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / +
页数：3
相关论文
共 50 条
  • [41] Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma
    Buquicchio, Rosalba
    Mastrandrea, Valentina
    Strippoli, Sabino
    Quaresmini, Davide
    Guida, Michele
    Filotico, Raffaele
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Simultaneous response of cutaneous and lung squamous cell carcinoma with cemiplimab
    Escobar, Gabriela Fortes
    Granel-Brocard, Florence
    Schmutz, Jean-Luc
    Cervantes, Pierre
    Ben Mahmoud, Sinan
    Bursztejn, Anne-Claire
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [43] Combination of Cemiplimab and Radiotherapy in Advanced Squamous Cell Carcinoma
    Martins, Andre Aparicio
    Teixeira, Joao
    Vieira, Ricardo
    Coutinho, Ines
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2025, 15 (01):
  • [44] Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma
    Geidel, Glenn
    Adam, Laura
    Ruenger, Alessandra
    Menz, Anne
    Koett, Julian
    Haalck, Thomas
    Gebhardt, Christoffer
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1414 - E1416
  • [45] Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios
    Akhtar, Komal
    Sravanthi, Metlapalli Venkata
    D'Angelo, Josephine
    Sivapiragasam, Abirami
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [46] PD-1 Blockade with Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 73 - 73
  • [47] Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis
    Di Raimondo, Cosimo
    Rao, Ludovico
    Lozzi, Flavia
    Lombardo, Paolo
    Silvaggio, Dionisio
    Vellucci, Laura
    Tofani, Lorenzo
    Campione, Elena
    Bianchi, Luca
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [48] Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion
    Argenziano, Giuseppe
    Fargnoli, Maria Concetta
    Fantini, Fabrizio
    Gattoni, Massimo
    Gualdi, Giulio
    Pastore, Francesco
    Pellacani, Giovanni
    Quaglino, Pietro
    Queirolo, Paola
    Troiani, Teresa
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [49] Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma (vol 80, pg 813, 2020)
    Lee, Arnold
    Duggan, Sean
    Deeks, Emma D.
    DRUGS, 2020, 80 (09) : 939 - 939
  • [50] Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside
    Goodman, D. T.
    JPRAS OPEN, 2022, 33 : 155 - 160
12345